Pharmabiz22m
Cipher Pharma announces Moberg Pharma’s nail fungus treating product MOB-015 fails to meet primary endpoint in phase 3 study
Cipher Pharma announces Moberg Pharma’s nail fungus treating product MOB-015 fails to meet primary endpoint in phase 3 study: Mississauga Thursday, December 12, 2024, 18:00 Hrs ...
Pharmabiz43m
FIP releases new skills reference guide focuses on pharmacists supporting self-care for Universal Health Coverage Day
FIP releases new skills reference guide focuses on pharmacists supporting self-care for Universal Health Coverage Day: Our Bureau, Bengaluru Thursday, December 12, 2024, 17:40 Hrs ...
Pharmabiz52m
MannKind and Cipla announce CDSCO approves Afrezza inhalation powder in India
MannKind and Cipla announce CDSCO approves Afrezza inhalation powder in India: Our Bureau, Mumbai Thursday, December 12, 2024, 17:30 Hrs [IST] MannKind Corporation, a company focu ...
Pharmabiz1h
Akoya Biosciences, NeraCare ink license agreement to develop & commercialize Immunoprint test for early-stage melanoma
Akoya Biosciences, NeraCare ink license agreement to develop & commercialize Immunoprint test for early-stage melanoma: Marlborough, Massachusetts Thursday, December 12, 2024, 17: ...
Pharmabiz1h
AGI Greenpac expands global pharmaceutical packaging footprint with new Dubai office
AGI Greenpac expands global pharmaceutical packaging footprint with new Dubai office: Our Bureau, Mumbai Thursday, December ...
Pharmabiz1h
Spruce Biosciences announces topline results from CAHmelia-204, CAHptain-205 in adult and paediatric congenital adrenal hyperplasia
South San Franciso, California Thursday, December 12, 2024, 16:30 Hrs [IST] ...
Pharmabiz2h
NeurAxis receives US FDA 510(k) clearance for RED for testing and evaluation of patients with chronic constipation
NeurAxis receives US FDA 510(k) clearance for RED for testing and evaluation of patients with chronic constipation: Carmel, Indiana Thursday, December 12, 2024, 16:00 Hrs [IST] Ne ...
Pharmabiz2h
Waters highlights continued progress towards sustainability commitments to reduce environmental impact
Waters highlights continued progress towards sustainability commitments to reduce environmental impact: Our Bureau, Bengaluru Thursday, December 12, 2024, 15:40 Hrs [IST] Waters h ...
Pharmabiz3h
AHPI unites corporate healthcare leaders to launch consortium for a TB-Free Uttar Pradesh
AHPI unites corporate healthcare leaders to launch consortium for a TB-Free Uttar Pradesh: Our Bureau, Mumbai Thursday, December 12, 2024, 15:20 Hrs [IST] In a groundbreaking init ...
Pharmabiz3h
NIH study finds tecovirimat was safe but did not improve mpox resolution or pain
NIH study finds tecovirimat was safe but did not improve mpox resolution or pain: Bethesda, Maryland Thursday, December 12, 2024, 15:00 Hrs [IST] The antiviral drug tecovirimat di ...
Pharmabiz4h
UK MHRA grants marketing authorization to Leo Pharma’s delgocitinib to treat adult patients with moderate to severe chronic hand eczema
UK MHRA grants marketing authorization to Leo Pharma’s delgocitinib to treat adult patients with moderate to severe chronic hand eczema: United Kingdom Thursday, December 12, 20 ...
Pharmabiz4h
Orbis India sees bright future begins with clear vision calls for early eye care in children
Orbis India sees bright future begins with clear vision calls for early eye care in children: Our Bureau, Bengaluru Thursday, December 12, 2024, 13:50 Hrs [IST] Orbis India, a non ...